Asymmetric conformational maturation of HIV-1 reverse transcriptase

eLife

Volumn 4, Issue JUNE, 2015, Pages 1-24

  Zheng, Xunhai ^a   Perera, Lalith ^a   Mueller, Geoffrey A ^a   DeRose, Eugene F ^a   London, Robert E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CHEMICAL PHENOMENA; CONFORMATIONAL TRANSITION; DIMERIZATION; ISOMERIZATION; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; SIMULATION; STRUCTURE ANALYSIS; CHEMISTRY; ENZYMOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; PROCEDURES; PROTEIN CONFORMATION; PROTEIN FOLDING; SIZE EXCLUSION CHROMATOGRAPHY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CHROMATOGRAPHY, GEL; DIMERIZATION; HIV REVERSE TRANSCRIPTASE; HIV-1; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 84933045705     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.06359     Document Type: Article

References (34)

1. Abram ME, Parniak MA. 2005. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain. Journal of Virology 79: 11952-11961. doi: 10.1128/JVI.79.18.11952-11961.2005.
2. Anderson SF, Coleman JE. 1992. Conformational-changes of Hiv reverse-transcriptase subunits on formation of the heterodimer-correlation with K(Cat) and K(M). Biochemistry 31:8221-8228. doi: 10.1021/bi00150a015.
3. Balzarini J, Auwerx J, Rodriguez-Barrios F, Chedad A, Farkas V, Ceccherini-Silberstein F, Garcia-Aparicio C, Velazquez S, De Clercq E, Perno CF, Camarasa MJ, Gago F. 2005. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors. Molecular Pharmacology 68:49-60.
4. Bavand MR, Wagner R, Richmond TJ. 1993. HIV-1 reverse transcriptase: polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer. Biochemistry 32:10543-10552. doi: 10.1021/bi00091a003.
5. Belshaw R, Pybus OG, Rambaut A. 2007. The evolution of genome compression and genomic novelty in RNA viruses. Genome Research 17:1496-1504. doi: 10.1101/gr.6305707.
6. Braz VA, Holladay LA, Barkley MD. 2010. Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers. Biochemistry 49:601-610. doi: 10.1021/bi901579y.
7. Case DA, Cheatham TE III, Darden T, Gohlke H, Luo R, Merz KM Jr, Onufriev A, Simmerling C, Wang B, Woods RJ. 2005. The Amber biomolecular simulation programs. Journal of Computational Chemistry 26:1668-1688. doi: 10. 1002/jcc.20290.
8. Das K, Clark AD Jr, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Béthune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, Arnold E. 2004. Roles of conformational and positional adaptability in structurebased design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Journal of Medicinal Chemistry 47:2550-2560. doi: 10.1021/jm030558s.
9. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. 1995. Nmrpipe-a multidimensional spectral processing system based on Unix Pipes. Journal of Biomolecular NMR 6:277-293. doi: 10.1007/ BF00197809.
10. Ding J, Jacobo-Molina A, Tantillo C, Lu X, Nanni RG, Arnold E. 1994. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer. Journal of Molecular Recognition 7:157-161. doi: 10.1002/jmr.300070212.
11. Dufour E, El Dirani-Diab R, Boulme F, Fournier M, Nevinsky G, Tarrago-Litvak L, Litvak S, Andreola ML. 1998. p66/ p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1-Interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors. European Journal of Biochemistry 251:487-495. doi: 10.1046/j.1432-1327.1998.2510487.x.
12. Ghosh M, Jacques PS, Rodgers DW, Ottman M, Darlix JL, Le Grice SF. 1996. Alterations to the primer grip of p66.
13. HIV-1 reverse transcriptase and their consequences for template-primer utilization. Biochemistry 35:8553-8562. doi: 10.1021/bi952773j.
14. Goel R, Beard WA, Kumar A, Casas-Finet JR, Strub MP, Stahl SJ, Lewis MS, Bebenek K, Becerra SP, Kunkel TA, Wilson SH. 1993. Structure-function studies of Hiv-1 reverse-transcriptase-dimerization-defective mutant L289K. Biochemistry 32:13012-13018. doi: 10.1021/bi00211a009.
15. Hostomska Z, Matthews DA, Davies JF, Nodes BR, Hostomsky Z. 1991. Proteolytic release and crystallization of the Rnase-h domain of human-immunodeficiency-virus type-1 reverse-transcriptase. Journal of Biological Chemistry 266:14697-14702.
16. Hsiou Y, Ding J, Das K, Clark AD Jr, Hughes SH, Arnold E. 1996. Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure 4:853-860.
17. Johnson BA, Blevins RA. 1994. Nmr view-a computer-program for the visualization and analysis of Nmr data. Journal of Biomolecular NMR 4:603-614. doi: 10.1007/BF00404272.
18. Kleiman L, Jones CP, Musier-Forsyth K. 2010. Formation of the tRNALys packaging complex in HIV-1. FEBS Letters 584:359-365. doi: 10.1016/j.febslet.2009.11.038.
19. Kupce E, Freeman R. 1995. Adiabatic pulses for wide-band inversion and broad-band decoupling. Journal of Magnetic Resonance 115:273-276. doi: 10.1006/jmra.1995.1179.
20. Marko RA, Liu HW, Ablenas CJ, Ehteshami M, Gotte M, Cosa G. 2013. Binding kinetics and affinities of heterodimeric versus homodimeric HIV-1 reverse transcriptase on DNA-DNA substrates at the single-molecule level. The Journal of Physical Chemistry B 117:4560-4567. doi: 10.1021/jp308674g.
21. Mulky A, Vu BC, Conway JA, Hughes SH, Kappes JC. 2007. Analysis of amino acids in the beta 7-beta 8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication. Journal of Molecular Biology 365:1368-1378. doi: 10.1016/j.jmb.2006.10.089.
22. Perelson AS, Nelson PW. 1999. Mathematical analysis of HIV-1 dynamics in vivo. Siam Review 41:3-44. doi: 10. 1137/S0036144598335107.
23. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586. doi: 10.1126/science.271.5255.1582.
24. Sharaf NG, Poliner E, Slack RL, Christen MT, Byeon IJ, Parniak MA, Gronenborn AM, Ishima R. 2014. The p66 immature precursor of HIV-1 reverse transcriptase. Proteins 82:2343-2352. doi: 10.1002/prot.24594.
25. Smallcombe SH, Patt SL, Keifer PA. 1995. WET solvent suppression and its applications to LC NMR and highresolution NMR spectroscopy. Journal of Magnetic Resonance, Series A 117:295-303. doi: 10.1006/jmra.1995. 0759.
26. Srivastava S, Sluis-Cremer N, Tachedjian G. 2006. Dimerization of human immunodeficiency virus type 1 reverse transcriptase as an antiviral target. Current Pharmaceutical Design 12:1879-1894. doi: 10.2174/ 138161206776873590.
27. Tugarinov V, Kay LE. 2003. Ile, Leu, and Val methyl assignments of the 723-residue malate synthase G using a new labeling strategy and novel NMR methods. Journal of the American Chemical Society 125:13868-13878. doi: 10. 1021/ja030345s.
28. Unge T, Knight S, Bhikhabhai R, Lovgren S, Dauter Z, Wilson K, Strandberg B. 1994. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure 2:953-961. doi: 10.1016/S0969-2126(94)00097-2.
29. Upadhyay A, Pandey N, Mishra CA, Talele TT, Pandey VN. 2010. A single deletion at position 134, 135, or 136 in the beta 7-Beta 8 loop of the p51 subunit of HIV-1 RT disrupts the formation of heterodimeric enzyme. Journal of Cellular Biochemistry 109:598-605. doi: 10.1002/jcb.22439.
30. Venezia CF, Howard KJ, Ignatov ME, Holladay LA, Barkley MD. 2006. Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Biochemistry 45:2779-2789. doi: 10.1021/bi051915z.
31. Venezia CF, Meany BJ, Braz VA, Barkley MD. 2009. Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits. Biochemistry 48:9084-9093. doi: 10.1021/bi9010495.
32. Zheng X, Mueller GA, Cuneo MJ, DeRose EF, London RE. 2010. Homodimerization of the p51 subunit of HIV-1 reverse transcriptase. Biochemistry 49:2821-2833. doi: 10.1021/bi902116z.
33. Zheng X, Mueller GA, Derose EF, London RE. 2012. Metal and ligand binding to the HIV-RNase H active site are remotely monitored by Ile556. Nucleic Acids Research 40:10543-10553. doi: 10.1093/nar/gks791.
34. Zheng X, Pedersen LC, Gabel SA, Mueller GA, Cuneo MJ, DeRose EF, Krahn JM, London RE. 2014. Selective unfolding of one Ribonuclease H domain of HIV reverse transcriptase is linked to homodimer formation. Nucleic Acids Research 42:5361-5377. doi: 10.1093/nar/gku143.